Similar articles

• Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.

  Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PA. Leysen JE, et al. J Pharmacol Exp Ther. 1988 Jan;244(1):310-21. J Pharmacol Exp Ther. 1988. PMID: 3336007
• Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.

  Tessel RE, Rutledge CO. Tessel RE, et al. J Pharmacol Exp Ther. 1976 May;197(2):253-62. J Pharmacol Exp Ther. 1976. PMID: 1271279
• Metabolic rates and multiple functional pools of brain biogenic amines: their significance in neuroendocrine regulation.

  Hyyppä MT. Hyyppä MT. Med Biol. 1974 Jun;52(3):170-5. Med Biol. 1974. PMID: 4418205 No abstract available.
• The interactions of tricyclic antidepressants with the biogenic amine uptake systems in the central nervous system.

  Horn AS. Horn AS. Postgrad Med J. 1976;52(3 suppl):25-32. Postgrad Med J. 1976. PMID: 785422 Review. No abstract available.
• Biogenic amines in the developing brain.

  Eiduson S. Eiduson S. UCLA Forum Med Sci. 1971;14:391-418. UCLA Forum Med Sci. 1971. PMID: 4399509 Review. No abstract available.